23Strands unlocks the power of DNA, providing insights into current and future best suited medication and disease risk based on DNA.
23Strands was founded in 2018 by Mark GROSSER, Vinayak Smith.
1282 health care and life sciences companies are in the directory, 519 of them in the same 11-50 employee range and 156 based in Asia-Pacific (APAC).
23Strands may be growing as evidenced by their collaboration with Monash University and the receipt of funding for a study on how whole genome sequencing can improve patient outcomes in IVF. This study is highlighted as the first of its kind, indicating an expansion in research and development within the biotechnology and healthcare industry. Additionally, the partnership with Virtus and the support from external funding sources suggest an increase in operational activities and potential for innovation in medical applications.
“Our vision is to empower every human being in their healthcare journey with genomics.” 23strands.com
Founded in 2018, 23Strands works in biotechnology, health care and medical from Asia-Pacific (APAC) and has 11-50 employees. It has raised $5 million over 2 rounds and its founders are Mark GROSSER and Vinayak Smith.
11-50 employees · acmbiolabs.com
11-50 employees · airna.com
11-50 employees · activmedresearch.com
11-50 employees · abanalitica.com
11-50 employees · adslaboratories.com
11-50 employees · artbio.com
11-50 employees · abferopharmaceuticals.com
11-50 employees · adarx.com
51-100 employees · als.net
51-100 employees · aoporphan.com
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.